Pharmafile Logo

Wilmington Healthcare appoints new Solutions Director

May 27, 2021 | NHS, Promotion, healthcare 

Kirsty Fryer has been promoted to the role of Solutions Director for Wilmington Healthcare

Wilmington Healthcare, a market leader in the provision of data, insight and intelligence for pharma and medtech companies, has announced the promotion of Kirsty Fryer to the role of Solutions Director.

In her new role, Kirsty will be responsible for the Quantis portfolio of products offered by Wilmington Healthcare, leading the team as they continue to deliver outstanding service and solutions to the organisation’s customers. Bringing together all disciplines, from analytical, development, commercial and marketing to underpin Wilmington Healthcare’s ambitious growth plans, Kirsty will ensure customers continue to receive trusted insight and real-world data solutions.

Kirsty steps up to the role having been Solutions Consultant since November 2017 and a valued member of the Wilmington Healthcare team since 2015. In this time, she has developed her career from bespoke researcher supporting the organisation’s understanding of the healthcare ecosystem before joining the solutions team working with real-world evidence – transforming data-led insight into core messages and potential implications. With a PhD in Neurophysiology from the University of Nottingham and currently undertaking an MBA with senior leadership focus she brings a wealth of expertise to the role alongside her existing client relationships.

Welcoming the appointment Jonathan Carney, of Wilmington Healthcare, says: “Kirsty has been a huge asset to Wilmington Healthcare since she joined the company in 2015. Her promotion to lead one of our key growth products in the role of Solutions Director is recognition for her passion, energy and commitment in delivering the very best for our customers combined with her extensive knowledge of our products and the impact they help to make in shaping sustainable commercial and partnership strategies for our customers. Through Kirsty’s appointment we will be building upon our market credentials as a trusted, leading organisation in the Healthcare Insight arena.”

Kirsty Fryer adds: ‘I’m proud of my work over the last five years within Wilmington Healthcare and I’m excited to guide our fantastic team as we continue to provide bespoke, real-world insight to meet the individual needs of our customers in parallel with the evolving needs of the NHS in this new era of healthcare impacted by the COVID-19 pandemic.”

This content was provided by Wilmington Healthcare

Company Details

 Latest Content from  Wilmington Healthcare 

Wilmington Healthcare makes new senior appointment

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has promoted a longstanding employee, Shelley Jessop, to the role of Account Director.Shelley who has worked for Wilmington...

Wilmington Healthcare appoints new Account Director

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has strengthened its salesforce with the appointment of Gareth Thurston as Account Director.

What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?

Paul Midgley, Director of NHS Insight at Wilmington Healthcare, explains how pharma should tailor its approach

How will the NHS’s new medicines savings drive affect pharma?

Steve How and Sue Thomas, of Wilmington Healthcare, explore how pharma should engage with CCGs on prescribing saving targets

Launch of the HSJ Partnership Awards: a programme for inspirational organisations helping to transform the NHS

New Awards will recognise the many private sector organisations who partner with the NHS to deliver improved patient outcomes and cost-effective care

How can pharma help the NHS capitalise on its data?

Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services

How can pharma engage with Accountable Care Systems?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain how pharma can add value across care pathways

New analysis shows emergency hospital admissions for people with Multiple Sclerosis continue to rise

Updated data published by Wilmington Healthcare and the MS Trust highlights need for more preventative care for MS patients

How will capitated budgets affect NHS spending?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the implications of a single budget covering all the physical, mental and social care needs of patients in an STP

Wilmington Healthcare launches new, integrated, digital channel to help pharma engage with the NHS

Healthcare intelligence provider Wilmington Healthcare has integrated its tools and resources online to help pharma navigate changes within the NHS, following the official launch of Sustainability and Transformation Plans (STPs)....